Mekki Q

References (3)

Title : Pharmacokinetics of alogliptin when administered with food, metformin, or cimetidine: a two-phase, crossover study in healthy subjects - Karim_2010_Int.J.Clin.Pharmacol.Ther_48_46
Author(s) : Karim A , Covington P , Christopher R , Davenport M , Fleck P , Li X , Wann E , Mekki Q
Ref : Int J Clinical Pharmacology & Therapeutics , 48 :46 , 2010
Abstract :
PubMedSearch : Karim_2010_Int.J.Clin.Pharmacol.Ther_48_46
PubMedID: 20040339

Title : Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study - Nauck_2009_Int.J.Clin.Pract_63_46
Author(s) : Nauck MA , Ellis GC , Fleck PR , Wilson CA , Mekki Q
Ref : Int J Clin Pract , 63 :46 , 2009
Abstract :
PubMedSearch : Nauck_2009_Int.J.Clin.Pract_63_46
PubMedID: 19125992

Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy - Pratley_2009_Diabetes.Obes.Metab_11_167
Author(s) : Pratley RE , Kipnes MS , Fleck PR , Wilson C , Mekki Q
Ref : Diabetes Obes Metab , 11 :167 , 2009
Abstract :
PubMedSearch : Pratley_2009_Diabetes.Obes.Metab_11_167
PubMedID: 19125778